Purchase this article with an account.
Ryan D. Makin, Ivana Apicella, Yosuke Nagasaka, Hiroki Kaneko, Stephen D. Turner, Nagaraj Kerur, Jayakrishna Ambati, Bradley D. Gelfand; RF/6A Chorioretinal Cells Do Not Display Key Endothelial Phenotypes. Invest. Ophthalmol. Vis. Sci. 2018;59(15):5795-5802. https://doi.org/10.1167/iovs.18-25215.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
The misuse of inauthentic cell lines is widely recognized as a major threat to the integrity of biomedical science. Whereas the majority of efforts to address this have focused on DNA profiling, we sought to anatomically, transcriptionally, and functionally authenticate the RF/6A chorioretinal cell line, which is widely used as an endothelial cell line to model retinal and choroidal angiogenesis.
Multiple vials of RF/6A cells obtained from different commercial distributors were studied to validate their genetic, transcriptomic, anatomic, and functional fidelity to bona fide endothelial cells.
Transcriptomic profiles of RF/6A cells obtained either de novo or from a public data repository did not correspond to endothelial gene expression signatures. Expression of established endothelial markers were very low or undetectable in RF/6A compared to primary human endothelial cells. Importantly, RF/6A cells also did not display functional characteristics of endothelial cells such as uptake of acetylated LDL, expression of E-selectin in response to TNF-α exposure, alignment in the direction of shear stress, and AKT and ERK1/2 phosphorylation following VEGFA stimulation.
Multiple independent sources of RF/6A do not exhibit key endothelial cell phenotypes. Therefore, these cells appear unsuitable as surrogates for choroidal or retinal endothelial cells. Further, cell line authentication methods should extend beyond genomic profiling to include anatomic, transcriptional, and functional assessments.
This PDF is available to Subscribers Only